Transmural Biotech

Curated by Signal

Web-based application for fetal lung maturity test based on ultrasound images

Life Sciences Technologytransmuralbiotech.com

Overview

Web-based application for fetal lung maturity test based on ultrasound images. The company's flagship platform is called quantusFLM. The platform uses a 4-chamber-view fetal ultrasound to provide the result about the baby’s lung maturity. Thus, the platform provides a non-invasive way of diagnosing prenatal lung maturity.

Key facts

Founded: 2009
Headquarters: Barcelona, Spain
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

3 products and services: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Dreamgenics
Services and products for clinical genomics and genomic research.
Life Sciences TechnologyLlanera, Spain
Bioprognos
Provider of Algorithm-based prognostic tests for the detection of cancer
Life Sciences TechnologyBarcelona, Spain
Kitazato
In-vitro fertilization and artificial reproductive therapy products
Life Sciences TechnologyValencia, Spain

About Transmural Biotech

What does Transmural Biotech do?

Web-based application for fetal lung maturity test based on ultrasound images.

Where is Transmural Biotech headquartered?

Transmural Biotech is headquartered in Barcelona, Spain.

When was Transmural Biotech founded?

Transmural Biotech was founded in 2009.

Which sector is Transmural Biotech in?

Transmural Biotech operates in Life Sciences Technology.

Who are Transmural Biotech's competitors?

Companies similar to Transmural Biotech include Dreamgenics, Bioprognos, and Kitazato.